| 000 | 01845 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516213619.0 | ||
| 264 | 0 | _c20150330 | |
| 008 | 201503s 0 0 eng d | ||
| 022 | _a1768-3254 | ||
| 024 | 7 |
_a10.1016/j.ejmech.2014.05.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKowalski, Konrad | |
| 245 | 0 | 0 |
_aFerrocenyl and dicobalt hexacarbonyl chromones--new organometallics inducing oxidative stress and arresting human cancer cells in G2/M phase. _h[electronic resource] |
| 260 |
_bEuropean journal of medicinal chemistry _cJun 2014 |
||
| 300 |
_a289-300 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCell Cycle Checkpoints _xdrug effects |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aChromones _xchemistry |
| 650 | 0 | 4 |
_aCobalt _xchemistry |
| 650 | 0 | 4 |
_aDNA _xchemistry |
| 650 | 0 | 4 | _aDNA Damage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 |
_aFerrous Compounds _xchemistry |
| 650 | 0 | 4 |
_aG2 Phase _xdrug effects |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMCF-7 Cells |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aOrganometallic Compounds _xchemical synthesis |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aHikisz, Paweł | |
| 700 | 1 | _aSzczupak, Łukasz | |
| 700 | 1 | _aTherrien, Bruno | |
| 700 | 1 | _aKoceva-Chyła, Aneta | |
| 773 | 0 |
_tEuropean journal of medicinal chemistry _gvol. 81 _gp. 289-300 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejmech.2014.05.023 _zAvailable from publisher's website |
| 999 |
_c23847950 _d23847950 |
||